Postoperative radiotherapy in head and neck mucosal melanoma: A GETTEC study

Archives of Otolaryngology - Head and Neck Surgery

Volumn 136, Issue 12, 2010, Pages 1219-1225

  Benlyazid, Adil ^a   Thariat, Juliette ^b   Temam, Stephane ^c   Malard, Olivier ^d   Florescu, Carmen ^e   Choussy, Olivier ^f   Makeieff, Marc ^g   Poissonnet, Gilles ^b   Penel, Nicolas ^h   Righini, Christian ⁱ   Toussaint, Bruno ^j   Lacau St Guily, Jean ^k   Vergez, Sebastien ^l   Filleron, Thomas ^a  

^a INSTITUT CLAUDIUS REGAUD   (France)

^b CENTRE ANTOINE LACASSAGNE   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d NANTES UNIVERSITY HOSPITAL   (France)

^e François Baclesse Institute   (France)

^f ROUEN UNIVERSITY HOSPITAL   (France)

^g MONTPELLIER UNIVERSITY HOSPITAL   (France)

^h CENTRE OSCAR LAMBRET   (France)

ⁱ INSTITUT ALBERT BONNIOT   (France)

^j UNIVERSITY HOSPITAL OF NANCY   (France)

^k HÔPITAL TENON   (France)

^l TOULOUSE UNIVERSITY HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; DEATH; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HEAD AND NECK MUCOSAL MELANOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; POSTOPERATIVE CARE; PROBABILITY; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; FRANCE; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; MUCOUS MEMBRANE; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE CARE; PROGNOSIS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 78650847354     PISSN: 08864470     EISSN: 1538361X     Source Type: Journal    
DOI: 10.1001/archoto.2010.217     Document Type: Article

References (23)

1. Seigler HF. Mucosal melanoma. J Surg Oncol. 2004;86(4):187-188.
2. Krengli M, Masini L, Kaanders JH, et al. Radiotherapy in the treatment of mucosal melanoma of the upper aerodigestive tract: analysis of 74 cases: a rare cancer network study. Int J Radiat Oncol Biol Phys. 2006;65(3):751-759.
3. Temam S, Mamelle G, Marandas P, et al. Postoperative radiotherapy for primary mucosal melanoma of the head and neck. Cancer. 2005;103(2):313-319. (Pubitemid 40129291)
4. Kalbfleish JD, Prentice RL. The Statistical Analysis of Failure Data. New York, NY: John Wiley & Sons; 1980:247-277.
5. Gelman R, Gelber R, Henderson IC, Coleman CN, Harris JR. Improved methodology for analyzing local and distant recurrence. J Clin Oncol. 1990;8(3):548-555.
6. Tai BC, Machin D, White I, Gebski V; EOI (European Osteosarcoma Intergroup). Competing risks analysis of patients with osteosarcoma: a comparison of four different approaches. Stat Med. 2001;20(5):661-684.
7. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16(3):1141-1154.
8. Fine J, Gray R. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496-509.
9. Collet D. Modeling Survival Data in Medical Research. London, England: Chapman & Hall; 1994: 251-273.
10. Hicks MJ, Flaitz CM. Oral mucosal melanoma: epidemiology and pathobiology. Oral Oncol. 2000;36(2):152-169.
11. Manolidis S, Donald PJ. Malignant mucosal melanoma of the head and neck: review of the literature and report of 14 patients. Cancer. 1997;80(8):1373- 1386. (Pubitemid 27441010)
12. Medina JE, Ferlito A, Pellitteri PK, et al. Current management of mucosal melanoma of the head and neck. J Surg Oncol. 2003;83(2):116-122. (Pubitemid 36667421)
13. Prasad ML, Patel SG, Huvos AG, Shah JP, Busam KJ. Primary mucosal melanoma of the head and neck: a proposal for microstaging localized, stage I (lymph node-negative) tumors. Cancer. 2004;100(8):1657-1664.
14. Andersen LJ, Berthelsen A, Hansen HS. Malignant melanoma of the upper respiratory tract and the oral cavity. J Otolaryngol. 1992;21(3):180-185.
15. Lee SP, Shimizu KT, Tran LM, Juillard G, Calcaterra TC. Mucosal melanoma of the head and neck: the impact of local control on survival. Laryngoscope. 1994;104(2):121-126.
16. Shah JP, Huvos AG, Strong EW. Mucosal melanomas of the head and neck. Am J Surg. 1977;134(4):531-535.
17. Penel N, Mallet Y, Mirabel X, Van JT, Lefebvre JL. Primary mucosal melanoma of head and neck: prognostic value of clear margins. Laryngoscope. 2006;116(6):993-995.
18. Patel SG, Prasad ML, Escrig M, et al. Primary mucosal malignant melanoma of the head and neck. Head Neck. 2002;24(3):247-257. (Pubitemid 34193249)
19. Lund VJ, Howard DJ, Harding L, Wei WI. Management options and survival in malignant melanoma of the sinonasal mucosa. Laryngoscope. 1999;109(2, pt 1):208-211. (Pubitemid 29075560)
20. Harrison DF. Malignant melanomata of the nasal cavity. Proc R Soc Med. 1968;61(1):13-18.
21. Schmidt-Ullrich RK, Johnson CR. Role of radiotherapy and hyperthermia in the management of malignant melanoma. Semin Surg Oncol. 1996;12(6):407-415. (Pubitemid 26371323)
22. Trotti A, Peters LJ. Role of radiotherapy in the primary management of mucosal melanoma of the head and neck. Semin Surg Oncol. 1993;9(3):246-250.
23. Sause WT, Cooper JS, Rush S, et al. Fraction size in external beam radiation therapy in the treatment of melanoma. Int J Radiat Oncol Biol Phys. 1991;20(3):429-432.